• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Selling Off-Label in HIV

Anonymous

Guest
I have worked with my manager several times since launch. We sold off-label the entire time. This is accepted and expected. My manager discussed the 96-week data at length when it was not even asked about. You cannot make your goals any other way.
 








I have worked with my manager several times since launch. We sold off-label the entire time. This is accepted and expected. My manager discussed the 96-week data at length when it was not even asked about. You cannot make your goals any other way.

Thanks for playing Merck. Game over. And bitching about it won't make it go away...
 












There is plenty room in HIV for off label, the difference is - if you are good and know what you are doing, you don't need to go there or feel compelled to

be careful..sounds like your RD doesn't know what he is doing

One whistleblower and you're all SOL